A Patient-LEVEL Simulation for Economic Evaluation of Vascular Service Reconfiguration in England

Author(s)

Tong T1, Thokala P1, Chilcott J2, Aber A1, Maheswaran R1, Michaels J1
1School of Health and Related Research (ScHARR), The University of Sheffield, SHEFFIELD, UK, 2ScHARR, University of Sheffield, Sheffield, UK

OBJECTIVES

:
We aim to develop a cost-effectiveness patient-level simulation of vascular services in England using analyses from Hospital Episode Statistics (HES) data and other information from the literature. The simulation can be used flexibly for the evaluation of different options for vascular service reconfiguration in England. The simulation has an interactive User Interface (UI) and can be accessed online at https://modellers.sheffield.ac.uk/vascularmodel.

METHODS

:
Three patient-level models for Abdominal Aortic Aneurysm, Carotid Artery Disease, and Peripheral Artery Disease were combined to develop an overall model. It captures not only the costs and outcomes of service reconfiguration but also the impacts from geographical areas at patient level, hospital level and regional level. HES data between April 2006 and March 2018 were analysed to provide the main inputs for the simulation. Data for utilities and other hospital costs (that are not available from HES data) were searched and extracted from the literature. All costs are reported in pounds sterling at year 2018 prices. Costs and outcomes were discounted at 3.5% per year. All statistical analyses and simulation were performed in R (Version 3.4.3).

RESULTS : AND CONCLUSIONS

:
The online application can be used to evaluate the impacts of vascular service reconfiguration in England. The interactive UI and the web-based application of the simulation are useful and novel features. Users can use the UI to customise their decision problems and run analyses to test different results. The model has been verified and validated. It can be used to analyse decisions to reconfigure vascular services at different areas in England regionally as well as nationally. Other potential areas of for further research indicates are further validation work to compare results from HES data with other data sources (i.e. clinical trials, observational studies). Future research can also look at model calibration and modelling discrepancy between the simulation and observation.

Conference/Value in Health Info

2020-09, ISPOR Asia Pacific 2020, Seoul, South Korea

Value in Health Regional, Volume 22S (September 2020)

Code

PSU6

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders, Surgery

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×